Within the past few years, information regarding osteocyte function as been emerging and expanding significantly. No longer is the osteocyte considered a passive cell acting simply as a 'placeholder' within mineralized bone. Osteocytes are derived from osteoblast progenitors and in the adult skeleton compose 90-95% of all bone cells. Therefore, the function of these cells in the adult and aging skeleton has become the focus of recent investigation. These cells are proving to be multifunctional, ranging from mechanotransduction, to regulation of mineral homeostasis, to control of bone remodeling. The osteocyte as a source and reservoir of signaling factors important in health and maintenance of the adult skeleton is addressed in this review.
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OSTEOCYTES AS MULTIFUNCTIONAL CELLS
Osteocytes are thought to be derived from matrix producing osteoblasts. Osteoblasts are dynamic cells that move along the bone surface before localizing in a targeted, predetermined location before becoming embedded in the newly forming osteoid bone matrix. However, once embedded, these cells can continue to move; their dendritic processes can extend and retract and the cell body can undulate within their lacunae [8] . Once embedded and differentiated into dendritic cells, osteocytes are clearly extremely sensitive to mechanical stimulation in the form of bone fluid flow shear stress. These cells signal not only other osteocytes, but both osteoblasts and osteoclasts and their precursors on the bone surface ( Fig.   1 ). Osteocytes are 'orchestrators' of bone remodeling sending signals of resorption and formation. The Wnt/β-catenin signaling pathway, recognized as an important regulator of bone mass and bone cell function, is also important in osteocytes to transmit signals of mechanical loading to cells on the bone surface [16] . The Wnt/ β-catenin pathway in osteocytes is triggered by crosstalk with the prostaglandin pathway in response to loading leading to a decrease in expression of negative regulators of the pathway such as Sost/ sclerostin and Dkk1 [6] .
Osteocytes appear to regulate both calcium and phosphate metabolism. Osteocytes can regulate calcium availability. The osteocyte can remove and replace their mineralized matrix under normal, healthy conditions such as lactation [21] . We propose that the term 'osteocytic remodeling' of their perilacunar and pericanalicular matrices be applied to pathological conditions such as hyperparathyroidism, whereas 'osteocytic remodeling' is the hallmark of a healthy osteocyte. The osteocyte appears to play a role in release of calcium from the bone matrix [2] especially in response to parathyroid hormone and parathyroid hormone related peptide. In addition to regulation of calcium, osteocytes appear to also regulate phosphate. Molecules such as phosphate regulating neutral endopeptidase on chromosome X (Phex), dentin matrix protein 1 (Dmp1), and fibroblast growth factor 23 (FGF23), are expressed by osteocytes [5] . Both Dmp1 and Phex appear to down regulate FGF23 expression which in turn allows reabsorption of phosphate by the kidney thereby maintaining sufficient circulating phosphate to maintain normal bone mineral content. In the absence of either Dmp1 or Phex, FGF23 is elevated in the osteocyte and systemically, leading to phosphate excretion by the kidney thereby lowering circulating phosphate resulting in osteomalacia and rickets. Based on these observations, we proposed that the osteocyte lacuna-canalicular network can function as an endocrine system, targeting distant organs such as kidney [9] .
OSTEOCYTES ARE HORMONALLY RESPONSIVE CELLS TO PARATHYROID HORMONE (PTH)
Mice expressing a constitutively active PTH/PTHrP receptor targeted to osteocytes have a dramatic increase in bone cortical thick- expression in osteocytes, suggesting that inhibition of phosphate reabsorption by PTH is due to its actions not only on the kidney, but also on osteocytes to increase production of circulating FGF23 [7] .
MECHANOTRANSDUCTION AND ACTIVATION OF SIGNALING PATHWAYS IN OSTEOCYTES
Clearly bone responds to both anabolic loading and to immobilization or unloading [14] . Several mechanisms have been proposed as to how osteocytes sense mechanical loading [4] . The osteocyte cell body, located within a lacunae, and its dendritic processes lo- 
OSTEOCYTE CELL DEATH
Osteocyte cell death, either as necrosis or apoptosis leads to activation of osteoclastic bone resoprtion. Death signaling pathways are activated in osteocytes during necrosis [25] or apoptosis [15] that induce signals of bone resorption. Recently we have shown that autophagy ('auto' self; 'phagy', eat; i.e. 'eating self') is a major means 
ACCESSIBILITY OF OSTEOCYTES
Because mature osteocytes are surrounded by a mineralized matrix they are difficult to isolate in significant numbers and purity. Osteocytes from immature bone such as chick and 1-2 week old mice can be isolated in reasonable numbers for experimentation [3, 14] . However, the older the animal, the more difficult this procedure becomes. To begin to tackle this problem, which is most likely the reason why osteocytes were ignored for years, cell lines were generated. Mikuni-Takagaki et al. [18] is not surrounded by a matrix-so it does not completely replicate the mature osteocyte within a mineralized matrix.
The MLO-A5 cell line overcomes many of the limitations of the MLO-Y4 cell line. This cell line is referred to as a late osteoblast, early osteoid-osteocyte cell line that produces very large amounts of alkaline phosphatase, osteocalcin, collagen, bone sialoprotein and mineralizes in the absence of an external source of phosphate with 7-9 days of culture [12] . The mineralization process of MLO-A5s has been characterized using a variety of high resolution microscopy techniques, and energy dispersive spectrometry and shown to be more bone-like than that of other osteoblast cell lines [1] . This cell line has proved useful to study the mineralization process, specifically the formation of nanospherulites, the response of cells in a 3 dimensional matrix to loading [24] , and recently, collagen and fibronectin assembly in the bone matrix [11] .
Recently, a third cell line, IDG-SW3, has been generated by crossing the Immortomouse with the Dmp1-GFP mouse [26] . 
THE OSTEOCYTE CAN TARGET AND CAN BE TARGETED BY BONE CELLS AND OTHER TISSUES
Can systemic factors reach the osteocyte? The osteocyte lacunacanalicular system is connected to the bone surface ( Fig. 1 ) and this system is maintained with bone remodeling (Fig. 2) . Clearly if one injects procian red into the tail vein of a mouse, within minutes the osteocyte lacuno-canalicular system is filled with the dye.
It has been shown that molecules less the 70 kDa, about the size of BSA, can travel through this network [10] . It has also been shown that bisphosphonates can target the osteocyte, as a fluorescent bisphosphonate has been shown to accumulate in osteocyte lacunae [22] .
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Therefore, one must assume that circulating factors, molecules, and drugs less than this particular size cutoff can reach the osteocyte.
One factor that appears to be produced by osteocytes is Sost/ sclerostin, an inhibitor of the Wnt/β-catenin pathway that functions by binding to Lrp 4, 5, and 6 [20] . Although produced in other cell types in the embryonic and developing skeleton, mainly mature osteocyte in the mature skeleton appear to produce this factor. Discovering that the increased bone mass condition, sclerosteosis, is caused by inactivating mutations of the Sost gene has lead to novel therapeutics focused on neutralizing the protein product, sclerostin. Neutralizing antibodies to sclerostin has bone anabolic effects and appears useful in not only treating bone loss such as postmenopausal bone loss and immune disease, but also in accelerating fracture repair and orthopedic conditions. This is an exciting new area of investigation.
CONCLUSIONS
In summary, far from being the quiescent cell as it is often referred to in textbooks, the osteocyte is a highly active cell type that regulates functions as diverse as mechanosensation, mineral homeostasis, and skeletal responses to hormonal signals. The molecular signaling pathways that regulate these diverse functions of the osteocytes are being identified and characterized (Table. 1 
Fig. 2.
Canaliculi bridge the reversal front. This suggests that during the remodeling process, osteocytes can connect their existing dendrites/canaliculi with newly formed dendrites/canaliculi of newly embedded osteocytes. In this manner, the connectivity of the osteocyte lacuno-canalicular network is maintained (1,000 x-human bone). 
